Premenstrual Syndrome
-
Subject Areas on Research
- Adrenergic receptors in premenstrual dysphoric disorder. II. Neutrophil beta2-adrenergic receptors: Gs protein coupling, phase of menstrual cycle and prediction of luteal phase symptom severity.
- Adrenergic receptors in premenstrual dysphoric disorder: I. Platelet alpha 2 receptors: Gi protein coupling, phase of menstrual cycle, and prediction of luteal phase symptom severity.
- Biological correlates of abuse in women with premenstrual dysphoric disorder and healthy controls.
- Comparison of lifetime psychiatric diagnoses in Premenstrual Syndrome Clinic and community samples.
- Cycle control with triphasic norgestimate and ethinyl estradiol, a new oral contraceptive agent.
- Daily moods and symptoms: Effects of awareness of study focus, gender, menstrual-cycle phase, and day of the week
- Debate on late luteal phase dysphoric disorder.
- Depressive symptoms and depressive diagnoses in a community population. Use of a new procedure for analysis of psychiatric classification.
- Differing symptoms of abused versus nonabused women in obstetric-gynecology settings.
- Improved premenstrual syndrome symptoms after NovaSure endometrial ablation.
- Late luteal phase dysphoric disorder.
- Low plasma gamma-aminobutyric acid levels during the late luteal phase of women with premenstrual dysphoric disorder.
- Major life events, daily stressors, and perimenstrual symptoms.
- New women-specific diagnostic modules: the Composite International Diagnostic Interview for Women (CIDI-VENUS).
- Paroxetine as a treatment for premenstrual dysphoric disorder.
- Premenstrual symptom changes and plasma beta-endorphin/beta-lipotropin throughout the menstrual cycle
- Premenstrual symptoms in black and white community samples.
- Recurrent premenstrual decline in serum lithium concentration: clinical correlates and treatment implications.
- Self-reported premenstrual exacerbation of depressive symptoms in patients seeking treatment for major depression.
- Serum progesterone levels following vaginal administration of progesterone during the luteal phase.
- Skating to where the puck is going to be: a plan for clinical trials and translation research in mood disorders.
- Statistical methods for two-sequence three-period cross-over designs with incomplete data.
- The effects of aerobic exercise on premenstrual symptoms in middle-aged women: a preliminary study.
- Urinary 6-hydroxymelatonin in menstruating women
- Using daily ratings to confirm premenstrual syndrome/late luteal phase dysphoric disorder. Part I. Effects of demand characteristics and expectations.
- Using daily ratings to confirm premenstrual syndrome/late luteal phase dysphoric disorder. Part II. What makes a "real" difference?
- Women's health issues with fibromyalgia syndrome.